Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|March 9, 2010
Pre T-cell receptor alpha (pTalpha) expression patterns and functional analysis in human T-cell lymphoblastic leukemiaPhilipp Ivanyi, Michael Morgan, Wenji Piao, et al.
World Journal of Urology|March 16, 2010
Carboplatin plus weekly docetaxel as salvage chemotherapy in docetaxel-resistant and castration-resistant prostate cancerChristoph W M Reuter, Michael A Morgan, Philipp Ivanyi, et al.
Cancer Investigation|October 14, 2022
Anti-EGFR-Based Therapy in Recurrent or Metastatic HNSCC - What Difference Does it Make?Hendrik Eggers, Lea Häbel, Arnold Ganser, et al.
Aktuelle Urologie|December 1, 2021
[Interdisciplinary recommendations for the treatment of advanced renal cell carcinoma]Kurt Miller, Lothar Bergmann, Christian Doehn, et al.
Scientific Reports|August 13, 2021
Prognostic role of docetaxel-induced suppression of free testosterone serum levels in metastatic prostate cancer patientsPaula Kappler, Michael A Morgan, Philipp Ivanyi, et al.
Scientific Reports|June 20, 2025
Impact of adding carboplatin to docetaxel chemotherapy on testosterone levels and treatment outcomes in metastatic docetaxel-resistant prostate cancerHejar Atalan, Michael A Morgan, Philipp Ivanyi, et al.
Oncology Research and Treatment|March 26, 2025
Treatment of Advanced or Metastatic Urothelial CancerThomas Hilser, Christopher Darr, Jens Bedke, et al.
Clinical Genitourinary Cancer|November 6, 2025
Real-World Experience With Lenvatinib Plus Everolimus (LEN+EVE) in Patients With Pretreated Advanced Renal Cell Carcinoma (RELEVANCE): A Retrospective, Multicenter Case SeriesHendrik Eggers, Ramona Stelmacher, Martin Bögemann, et al.
Aktuelle Urologie|July 24, 2026
[Perioperative Treatment with Durvalumab in Combination with Neoadjuvant Chemotherapy in Cisplatin-Eligible Patients with Muscle-Invasive Bladder Cancer]Marco Julius Schnabel, Marc-Oliver Grimm, Peter J Goebell, et al.
Experimental Hematology|August 26, 2011
Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability, and expansion capacitySya N Ukena, Matthias Höpting, Sarvari Velaga, et al.
Pageof 10